How Does Patient Input Affect Oncology Research And Policy?

Of course patients should play a role in making decisions related to their care, but what about during clinical trials, when important policy issues are being formed? How much does patient input matter then? Read more here. (Source: Maurie Markman, OncLive, 12/2/14).

You might also be interested in:

Are Biosimilars the Key to Boosting Access, Controlling Prices… July 19, 2018
RWE: Opportunity, Challenges and Sourcing Simplified November 30, 2018
eDossier System to Offer hēRo3 Model Integration November 8, 2018
Course to Focus on Better Use of RWE in Outcomes Measurements,… December 3, 2018
BioMedCentral’s Trials Issues Call for Papers May 24, 2018
HealthCore-NERI’s Singer Talks RWE, Pragmatic Clinical Trials January 21, 2019
Article: Value-Based Oncology Care Fails to Address… January 7, 2019